Putri, D. A., Setiawan, D., & Yamsun, M. (2025). Cost-Utility Analysis Addition of Bevacizumab to Standard Chemotherapy in KRAS-mutation Colorectal Cancer. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 22(1), 6–11. https://doi.org/10.30595/pharmacy.v22i1.24298